- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02190253
Seroprevalence of Hepatitis E in People With an Organ Transplant
Seroprevalence of Hepatitis E in The Organ Transplant Subjects
Background:
- The hepatitis E virus causes an acute hepatitis that usually goes away by itself. Researchers in France studied people who received a liver or kidney transplant. They found that hepatitis E may not go away by itself in these people. It becomes chronic. This can cause serious liver disease. More than half the people who had organ transplant who had hepatitis E seemed to get a chronic infection.
Researchers want to find out if hepatitis E happens this often in patients who have liver, kidney, or small bowel transplants in the United States. If it does, they want to know why. They want to know if chronic hepatitis E will become an important medical problem. This research might help improve care for people who have a transplant. It also might help researchers prevent the spread of hepatitis E.
Objective:
- To see how many patients who have received or are waiting for certain transplants have antibodies to hepatitis E virus.
Eligibility:
- Adults over age 18 who have had a liver, kidney, liver and kidney, or small bowel transplant, or are on a waiting list for one.
Design:
- Participants will be enrolled from 3 transplant centers.
- Participants will complete a questionnaire. They will be asked about possible risk factors for hepatitis E exposure.
- Participants will have a blood sample drawn through a needle placed in a vein.
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20007-2197
- Georgetown University
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104-6056
- University of Pennsylvania
-
-
Wisconsin
-
Madison, Wisconsin, United States, 53792
- University of Wisconsin
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
- ELIGIBILITY CRITERIA:
Inclusion criteria for post-transplant subjects
- Age greater than or equal to 18 years, male or female
- Recipients of either liver, kidney, liver and kidney, and small bowel transplants
- Survival for a minimum of 1 year post-transplant
- Willingness to provide written, informed consent
Exclusion criteria for post-transplant subjects:
- Current or previous treatment within the last year with peg-interferon and or ribavirin.
- Known history of hepatitis E infection.
Inclusion criteria for waitlist subjects:
- Age greater than or equal to 18 years, male or female
- Subjects on the waitlist for first liver, kidney, liver and kidney or small bowel transplant
- Willingness to provide written, informed consent
Exclusion criteria for waitlist subjects:
- Current or previous treatment within the last year with peg-interferon and or ribavirin.
- Current immunosuppression
- Known history of hepatitis E infection.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Organ transplant recipients
Recipients of either liver, kidney, liver and kidney, and small bowel transplants
|
Waitlist patients
Patients on waitlist for liver, kidney or intestinal transplantation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Seroprevalence of anti-HEV
Time Frame: Baseline
|
Seroprevalence of antibody to hepatitis E IgG
|
Baseline
|
Collaborators and Investigators
Investigators
- Principal Investigator: Marc G Ghany, M.D., National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Publications and helpful links
General Publications
- Pischke S, Wedemeyer H. Chronic hepatitis E in liver transplant recipients: a significant clinical problem? Minerva Gastroenterol Dietol. 2010 Jun;56(2):121-8.
- Gerolami R, Moal V, Picard C, Colson P. Hepatitis E virus as an emerging cause of chronic liver disease in organ transplant recipients. J Hepatol. 2009 Mar;50(3):622-4. doi: 10.1016/j.jhep.2008.12.008. Epub 2008 Dec 25. No abstract available.
- Haagsma EB, Niesters HG, van den Berg AP, Riezebos-Brilman A, Porte RJ, Vennema H, Reimerink JH, Koopmans MP. Prevalence of hepatitis E virus infection in liver transplant recipients. Liver Transpl. 2009 Oct;15(10):1225-8. doi: 10.1002/lt.21819.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 999914148
- 14-DK-N148
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hepatitis E
-
International Vaccine InstituteBill and Melinda Gates Foundation; Thrasher Research Fund; Open PhilanthropyNot yet recruiting
-
Xiamen UniversityCompletedHepatitis E Virus Infection
-
Norwegian Institute of Public HealthInternational Centre for Diarrhoeal Disease Research, Bangladesh; Sykehuset...CompletedHepatitis E InfectionBangladesh
-
Carmel Medical CenterUnknown
-
International Vaccine InstituteBill and Melinda Gates Foundation; Xiamen Innovax Biotech Co., LtdNot yet recruitingHepatitis E Virus Infection
-
All India Institute of Medical Sciences, New DelhiUnknownLiver Failure | Acute on Chronic Hepatic Failure | Hepatitis E InfectionIndia
-
Assistance Publique Hopitaux De MarseilleCompletedKidney-transplant Recipients With Chronic Hepatitis E Virus InfectionFrance
-
Central Hospital, Nancy, FranceUnknownHepatitis E Infection in Humans and in EnvironmentFrance
-
University of Maryland, BaltimoreAlexandria University; MADAUS GmbH; The Egyptian Company for Blood Transfusion... and other collaboratorsTerminatedAcute Hepatitis C | Acute Hepatitis B | Acute Hepatitis A | Acute Hepatitis E | Acute EBV Hepatitis | Acute CMV HepatitisEgypt
-
University Hospital, Basel, SwitzerlandKantonsspital St. Gallen, St. Gallen, SwitzerlandRecruitingLeptospirosis | Tularemia | Hepatitis E Virus InfectionSwitzerland